Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) in clinical practice

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Rare non-coding Desmoglein-2 variant contributes to Arrhythmogenic right ventricular cardiomyopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Long-Term Lung Function and Exercise Capacity in Postinfectious chILD

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Immune regulation by fibroblasts in tissue injury depends on uPARAP-mediated uptake of collectins

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The Effect of Mechanical Circulatory Support on HLA Antibodies and Antibody-Mediated Rejection in Cardiac Allografts

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  5. Effect of left ventricular assist device implantation on complement activation of the cardiac allograft in the early post-heart transplant course

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  • Ka Hou Christien Li
  • George Bazoukis
  • Tong Liu
  • Guangping Li
  • William K K Wu
  • Sunny Hei Wong
  • Wing Tak Wong
  • Yat Sun Chan
  • Martin C S Wong
  • Katharina Wassilew
  • Vassilios S Vassiliou
  • Gary Tse
Vis graf over relationer

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited myocardial disease characterized by fibro-fatty replacement of the right ventricular myocardium, and associated with paroxysmal ventricular arrhythmias and sudden cardiac death (SCD). It is currently the second most common cause of SCD after hypertrophic cardiomyopathy in young people <35 years of age, causing up to 20% of deaths in this patient population. This condition has a male preponderance and is more commonly found in individuals of Italian and Greek descent. To date, there is no single diagnostic test for ARVC/D and the diagnosis is made based on clinical, electrocardiographic, and radiological findings according to the Revised 2010 Task Force Criteria. In this review, we will discuss the mainstay treatment which includes pharmacotherapy, implantable cardioverter-defibrillator insertion for abortion of sudden cardiac death, and in the advanced stages of the disease cardiac transplantation.

OriginalsprogEngelsk
TidsskriftJournal of Arrhythmia
Vol/bind34
Udgave nummer1
Sider (fra-til)11-22
Antal sider12
ISSN1880-4276
DOI
StatusUdgivet - feb. 2018

ID: 56436954